TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Cullen To Leave NCI, Will Become Director Of AMC Cancer Center; Nixon May Join ACS April 14, 1989
TCL Archive Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House March 19, 1999
TCL Archive Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’ December 11, 1992
TCL Archive DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract March 16, 1984